Buscar
Mostrando ítems 21-30 de 600
Toxicogenomic activity of gemcitabine in two TP53-mutated bladder cancer cell lines: special focus on cell cycle-related genes
(Springer, 2012-12-01)
Because of its lower toxicity and good tolerability and response, gemcitabine has been described as one of the most highly promising drugs for urinary bladder cancer therapy. Its phosphorylated active-dFdCTP metabolite can ...
Toxicogenomic activity of gemcitabine in two TP53-mutated bladder cancer cell lines: special focus on cell cycle-related genes
(Springer, 2012-12-01)
Because of its lower toxicity and good tolerability and response, gemcitabine has been described as one of the most highly promising drugs for urinary bladder cancer therapy. Its phosphorylated active-dFdCTP metabolite can ...
Mutações no gene TP53 em tumores malignos de mama: associação com fatores de risco e características clínico-patológicas, inclusive risco de óbito, em pacientes residentes no Rio de JaneiroTP53 mutation in malignant breast tumors: association with risk factors and clinical-pathological characteristics, including risk of death, in patients from Rio de Janeiro
(Associação Brasileira de Saúde Coletiva, 2023)
Gene Mutations and Polymorphisms of TP53 and FHIT in Chronic Esophagitis and Esophageal Carcinoma
(Int Inst Anticancer Research, 2014)
Cytotoxic and toxicogenomic effects of silibinin in bladder cancer cells with different TP53 status
(Indian Acad Sciences, 2017-03-01)
Silibinin is a natural phenol found in the seeds of the milk thistle plant. Recent data have shown its effectiveness for preventing/treating bladder tumours. Therefore, in this study we investigated the cytotoxic and ...
Alterations of the TP53 Gene in Gastric and Esophageal Carcinogenesis
(Hindawi Publishing Corporation, 2014)
DNA methylation patterns of candidate genes regulated by thymine DNA glycosylase in patients with TP53 germline mutations
(Assoc Bras Divulg Cientifica, 2015)